Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

Clicks: 133
ID: 283399
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #1,502 of 1,628 articles by views in Scientific reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,628 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
Özyurt2025author Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors N. Özyurt; Ali Alkan; B. Gülbağcı; Mustafa Seyyar; Esra Aşık; Mustafa Şahbazlar; Mehmet Türker; Oğuzcan Kınıkoğlu; Tahir Yerlikaya; Gülhan Dinç; Ali Aytaç; Z. Kalkan; Senar Ebinç; Ilkay Gültürk; Merve Keskinkilic; Zehra Sucuoglu Isleyen; D. Çağlayan; Alper Türkel; Esra Aydın; T. Şakalar; Serhat Sekmek; N. Yıldırım; Sinem Koçak; K. Okutur; A. Özveren; B. Dursun; Sait Kitaplı; O. Eren; I. Beypınar; I. Hacibekiroglu; D. Çabuk; Elanur Karaman; Ömer Acar; S. Paydaş; M. Eryılmaz; B. Demi̇r; Z. Oruç; Mesut Yılmaz; F. Biricik; D. Salim; Özgür Tanrıverdi; M. Doğan
Journal Scientific reports
Year 2025
DOI
10.1038/s41598-024-80587-9
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.